(Reuters) -Moderna said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food and Drug Administration. The company said the submission for ...
Pharmaceutical company Pfizer has started its application to the U.S. Food and Drug Administration for full approval of its COVID-19 vaccine. Since December, Pfizer has been authorized on an emergency ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Moderna's decision to withdraw ...
Co-Diagnostics withdrew its 510(k) application for its COVID-19 test to submit an enhanced version addressing shelf-life stability concerns. The new submission will incorporate platform improvements, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback